• A2A Pharma

A2A Pharma 2nd Quarter Update

Updated: Feb 7, 2020

7 views0 comments

Recent Posts

See All

A2A co-founded biomea Fusion raises $56M

Biomea Fusion, Inc., a precision oncology company dedicated to developing innovative medicines targeting genomically defined alterations in both hematologic and solid cancers, announced the closing of

A2A Appoints New Advisors

Dr. Siddhartha Mukherjee, Dr. Annalisa Jenkins and Dr. Srikumar Chellappan join A2A’s Advisory Board. LEARN MORE


BioLabs New York
180 Varick Street
New York, NY 10014


Cambridge Innovation Center
1 Broadway 
Cambridge, MA 02142

© 2019 A2A Pharma. All rights reserved